death Ventilators patient

NHS gets breakthrough new Covid drug that slashes death rate by up to half

Reading now: 515

Two existing drugs have been shown to cut the chances of ventilated Covid-19 patients dying by almost half. The findings from a world-leading NHS clinical trial could save thousands of lives of people who end up needing oxygen.

The latest result of the 4,000-patient Recovery trial showed that using arthritis drug tocilizumab reduced death rates by 15%.

Taken alongside dexamethasone - the first drug previously shown to save lives of Covid patients - the benefit was even higher.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News